Sign Out
The fixed-dose combination Abacavir 600 mg / Lamivudine 300 mg tablets is contraindicated in patients with known hypersensitivity to the active substances or to any of the excipients. See Precautions on Abacavir Hypersensitivity Reactions.
Patients with severe hepatic impairment.
Continue with Google